EVOX THERAPEUTICS
DEAD

Serial Number

79209128

Owner

Evox Therapeutics Limited

Attorney

Bryce J. Maynard

Filing Date

Dec 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

EVOX THERAPEUTICS Trademark

Serial Number: 79209128

EVOX THERAPEUTICS is a trademark filed by Evox Therapeutics Limited on December 15, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Evox Therapeutics Limited (10 trademarks)

Oxford Science Park, Medawar Centre,

Entity Type: 99

Trademark Details

Filing Date

December 15, 2016

Registration Date

Not Registered

Goods & Services

Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders

Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 25, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 5, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2023 FICR
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Apr 5, 2022 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Apr 5, 2022 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Apr 5, 2022 ABN3
EXPARTE APPEAL TERMINATED
Apr 5, 2022 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Feb 22, 2022 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Dec 8, 2021 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Dec 8, 2021 GECD
ACTION CONTINUING FINAL - COMPLETED
Dec 8, 2021 CNCF
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2021 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2021 CRFA
EX PARTE APPEAL-INSTITUTED
Oct 20, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 20, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 20, 2021 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 19, 2021 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 19, 2021 GNS1
SUBSEQUENT FINAL EMAILED
Apr 19, 2021 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Apr 19, 2021 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 9, 2021 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 9, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 9, 2021 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 10, 2020 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 19, 2020 RCCK
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2020 NREP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 10, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 6, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 6, 2019 RCSC
ASSIGNED TO LIE
Feb 6, 2019 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 23, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 7, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 7, 2018 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 20, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 20, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jul 20, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 27, 2018 ERFR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 15, 2018 ADCH
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 10, 2018 GNFN
FINAL REFUSAL E-MAILED
Jan 10, 2018 GNFR
FINAL REFUSAL WRITTEN
Jan 10, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 13, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2017 REAP
REFUSAL PROCESSED BY IB
Jul 8, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 20, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jun 20, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 13, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jun 12, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 10, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 6, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 1, 2017 REPR